Skip to content

Blood Cancer United president reflects on 75 years of progress in blood cancer treatment
Dr. Krish Patel on frontline and relapsed management strategies in mantle cell lymphoma
Meet SOHO France Young Investigator Syrine Bel Haj Yahia
Drs. DiPersio and Scheinberg at SOHO Central Europe
FDA grants Breakthrough Designation to enzomenib for relapsed or refactory acute leukemia

Insider Reader Survey

Join SOHO

Insider Podcast
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Cellular Therapy

Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda

Trending now Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma News

FDA clears IND application for CD19/CD20 dual-targeting in vivo CAR-T therapy LB2501

by SOHO Insider Editors
October 15, 2026
0 Comments

Cellular Therapy Meetings / Conferences SOHO 2026

Posters not to miss: cellular therapy edition

by Krish Patel, MD
September 24, 2026
0 Comments

Cellular Therapy Leukemia Acute Lymphoblastic Leukemia Meetings / Conferences SOHO 2026 Acute Lymphoblastic Leukemia News News

Session sparks debate on whether chemotherapy is needed in ALL care

by Elias Jabbour, MD
September 7, 2026
0 Comments

Cellular Therapy Leukemia Acute Lymphoblastic Leukemia SOHO 2026 Acute Lymphoblastic Leukemia News Leukemia News News Video Interviews

Dr. DiPersio previews the SOHO 2026 ALL session to be held on Wednesday, September 9

by SOHO Insider Editors
September 2, 2026
0 Comments

Cellular Therapy Leukemia Acute Myeloid Leukemia

Phase 1 data reported for anti-CD123 CAR T-cell therapy in relapsed or refractory AML, BPDCN

by Patrick Daly
August 26, 2026
0 Comments

Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas EHA 2026 News Video Interviews

Dr. Ying Huang presents first-in-human data for in vivo CAR-T LB2501 in B-cell NHL

by SOHO Insider Editors
August 21, 2026
0 Comments

Cellular Therapy Leukemia Chronic Lymphocytic Leukemia Lymphoma Indolent B-Cell Lymphomas News

Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL

by Kerri Fitzgerald
August 20, 2026
0 Comments

Cellular Therapy Lymphoma

Post-transplantation outcomes have improved for Hodgkin lymphoma

by Leah Sherwood
August 13, 2026
0 Comments

Cellular Therapy Leukemia Acute Lymphoblastic Leukemia Meetings / Conferences EHA 2026

Nanobody-based anti-CD5 CAR T agent improves efficacy in relapsed or refractory T-cell ALL

by Patrick Daly
June 30, 2026
0 Comments

Cellular Therapy ASCO 2026 Multiple Myeloma News

Anito-cel manufacturing builds on CAR T-cell learnings in multiple myeloma trials

by Patrick Daly
June 8, 2026
0 Comments

1
2
3
...
9

Top Categories

Cellular Therapy

82

Leukemia

144

Lymphoma

143

Multiple Myeloma

126

Myelodysplastic Syndromes

52

Myeloproliferative Neoplasms

40

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Cellular Therapy

Posters not to miss: cellular therapy edition

Session sparks debate on whether chemotherapy is needed in ALL care

Dr. DiPersio previews the SOHO 2026 ALL session to be held on Wednesday, September 9

Phase 1 data reported for anti-CD123 CAR T-cell therapy in relapsed or refractory AML, BPDCN

Dr. Ying Huang presents first-in-human data for in vivo CAR-T LB2501 in B-cell NHL

Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL

Post-transplantation outcomes have improved for Hodgkin lymphoma

Nanobody-based anti-CD5 CAR T agent improves efficacy in relapsed or refractory T-cell ALL

Anito-cel manufacturing builds on CAR T-cell learnings in multiple myeloma trials

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Society Updates

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

Blood Cancer United president reflects on 75 years of progress in blood cancer treatment

Dr. Krish Patel on frontline and relapsed management strategies in mantle cell lymphoma

Meet SOHO France Young Investigator Syrine Bel Haj Yahia

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

Cellular Therapy

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Society Updates

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms